Abstract
Growing evidence has identified nocturia as a potential manifestation of several cardiovascular disease states. We aimed to determine whether a relationship exists between nocturia and global atherosclerotic cardiovascular disease (ASCVD) risk, defined by the American College of Cardiology/American Heart Association (ACC/AHA) ASCVD risk calculator, using a large nationally-representative study sample from the United States. We explored potential associations between nocturia and ASCVD risk in adults aged 40–79 years with no prior history of overt/known atherosclerotic disease from 7 consecutive cycles of the National Health and Nutrition Examination Survey. Subjects were classified by whether they met the ASCVD high-risk threshold following current ACC/AHA consensus guidelines (10-year major adverse cardiovascular event risk ≥ 20%). Logistic regression analyses were used to explore associations between nocturia (defined as ≥ 2 nocturnal voids) and ASCVD risk. The prevalence of nocturia and high ASCVD risk were 27.0% and 10.9%, respectively. Nocturia, older age, increased body mass index, and diuretic use were associated with high ASCVD risk on univariate logistic regression. After adjusting for age, body mass index, and diuretic use, nocturia remained associated with significantly greater odds of high ASCVD risk in females but not in males. Elicitation of nocturia on clinical history taking may serve to identify high cardiovascular risk in females. Future studies are needed to elucidate mechanisms underlying this association.
Similar content being viewed by others
Availability of data and materials
All data are publicly available.
References
Everaert, K., Anderson, P., Wood, R., Andersson, F. L., & Holm-Larsen, T. (2018). Nocturia is more bothersome than daytime LUTS: Results from an Observational, Real-life Practice Database including 8659 European and American LUTS patients. International Journal of Clinical Practice, 72(6), e13091. https://doi.org/10.1111/ijcp.13091.
Irwin, D. E., Milsom, I., Hunskaar, S., et al. (2006). Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study. European Urology, 50(6), 1306–1314; discussion 1314–1305. https://doi.org/10.1016/j.eururo.2006.09.019.
Bosch, J. L., & Weiss, J. P. (2013). The prevalence and causes of nocturia. Journal of Urology, 189(1 Suppl), S86-92. https://doi.org/10.1016/j.juro.2012.11.033.
Asplund, R., & Aberg, H. E. (2004). Nocturia in relation to body mass index, smoking and some other life-style factors in women. Climacteric, 7(3), 267–273. https://doi.org/10.1080/13697130400001398.
Kim, S. Y., Bang, W., Kim, M. S., Park, B., Kim, J. H., & Choi, H. G. (2017). Analysis of the prevalence and factors associated with nocturia in adult Korean men. Scientific Reports, 7, 41714. https://doi.org/10.1038/srep41714.
Kupelian, V., Fitzgerald, M. P., Kaplan, S. A., Norgaard, J. P., Chiu, G. R., & Rosen, R. C. (2011). Association of nocturia and mortality: Results from the Third National Health and Nutrition Examination Survey. Journal of Urology, 185(2), 571–577. https://doi.org/10.1016/j.juro.2010.09.108.
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., et al. (2014). 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 63(25, Part B), 2935–2959. https://doi.org/10.1016/j.jacc.2013.11.005.
Bouwman, I. I., Voskamp, M. J. H., Kollen, B. J., Nijman, R. J. M., van der Heide, W. K., & Blanker, M. H. (2015). Do lower urinary tract symptoms predict cardiovascular diseases in older men? A systematic review and meta-analysis. World Journal of Urology, 33(12), 1911–1920. https://doi.org/10.1007/s00345-015-1560-1.
Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Retrieved from https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Questionnaire. Accessed 1 Dec 2020.
Arnett, D. K., Blumenthal, R. S., Albert, M. A., et al. (2019). 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology, 74(10), 1376–1414. https://doi.org/10.1016/j.jacc.2019.03.009.
Monaghan, T. F., Gong, F., Vaysblat, M., et al. (2020). Nocturia: A marker of furosemide treatment response? An exploratory study. BJU International, 125(5), 636–637. https://doi.org/10.1111/bju.15017.
Markland, A. D., Vaughan, C. P., Johnson, T. M., 2nd., Goode, P. S., Redden, D. T., & Burgio, K. L. (2011). Prevalence of nocturia in United States men: Results from the National Health and Nutrition Examination Survey. Journal of Urology, 185(3), 998–1002. https://doi.org/10.1016/j.juro.2010.10.083.
Hall, S. A., Chiu, G. R., Kaufman, D. W., Wittert, G. A., Link, C. L., & McKinlay, J. B. (2012). Commonly used antihypertensives and lower urinary tract symptoms: Results from the Boston Area Community Health (BACH) Survey. BJU International, 109(11), 1676–1684. https://doi.org/10.1111/j.1464-410X.2011.10593.x.
Moon, S., Chung, H. S., Yu, J. M., et al. (2019). The association between obesity and the nocturia in the U.S. population. International Neurourology Journal, 23(2), 169–176. https://doi.org/10.5213/inj.1938062.031.
Yoshimura, K. (2012). Correlates for nocturia: A review of epidemiological studies. International Journal of Urology, 19(4), 317–329. https://doi.org/10.1111/j.1442-2042.2011.02956.x.
Gacci, M., Corona, G., Sebastianelli, A., et al. (2016). Male lower urinary tract symptoms and cardiovascular events: A systematic review and meta-analysis. European Urology, 70(5), 788–796. https://doi.org/10.1016/j.eururo.2016.07.007.
Garcia, M., Mulvagh, S. L., Merz, C. N. B., Buring, J. E., & Manson, J. E. (2016). Cardiovascular disease in women: Clinical perspectives. Circulation Research, 118(8), 1273–1293. https://doi.org/10.1161/CIRCRESAHA.116.307547.
Weiss, J. P., Blaivas, J. G., Stember, D. S., & Chaikin, D. C. (1999). Evaluation of the etiology of nocturia in men: The nocturia and nocturnal bladder capacity indices. Neurourology and Urodynamics, 18(6), 559–565.
Weiss, J. P., Blaivas, J. G., Stember, D. S., & Brooks, M. M. (1998). Nocturia in adults: Etiology and classification. Neurourology and Urodynamics, 17(5), 467–472.
Colombo, P. C., Onat, D., & Sabbah, H. N. (2008). Acute heart failure as “acute endothelitis”—Interaction of fluid overload and endothelial dysfunction. European Journal of Heart Failure, 10(2), 170–175. https://doi.org/10.1016/j.ejheart.2007.12.007.
Inci, M., Sarli, B., Davarci, M., et al. (2013). Relationship between endothelial dysfunction and nocturia with benign prostatic hyperplasia. Scandinavian Journal of Urology, 47(5), 384–389. https://doi.org/10.3109/21681805.2012.762038.
Tabara, Y., Matsumoto, T., Murase, K., et al. (2019). Frequent nocturnal urination in older men is associated with arterial stiffness: The Nagahama study. Hypertension Research, 42(12), 1996–2001. https://doi.org/10.1038/s41440-019-0309-4.
Torimoto, K., Hirayama, A., Samma, S., Yoshida, K., Fujimoto, K., & Hirao, Y. (2009). The relationship between nocturnal polyuria and the distribution of body fluid: Assessment by bioelectric impedance analysis. Journal of Urology, 181(1), 219–224; discussion 224. https://doi.org/10.1016/j.juro.2008.09.031.
Nomiya, M., Yamaguchi, O., Akaihata, H., et al. (2014). Progressive vascular damage may lead to bladder underactivity in rats. Journal of Urology, 191(5), 1462–1469. https://doi.org/10.1016/j.juro.2013.10.097.
Landau, E. H., Jayanthi, V. R., Churchill, B. M., et al. (1994). Loss of elasticity in dysfunctional bladders: Urodynamic and histochemical correlation. Journal of Urology, 152(2 Pt 2), 702–705. https://doi.org/10.1016/s0022-5347(17)32685-x.
Parsons, M., Amundsen, C. L., Cardozo, L., Vella, M., Webster, G. D., & Coats, A. C. (2007). Bladder diary patterns in detrusor overactivity and urodynamic stress incontinence. Neurourology and Urodynamics, 26(6), 800–806. https://doi.org/10.1002/nau.20406.
Smith, P. P., Chalmers, D. J., & Feinn, R. S. (2015). Does defective volume sensation contribute to detrusor underactivity? Neurourology and Urodynamics, 34(8), 752–756. https://doi.org/10.1002/nau.22653.
Pinggera, G. M., Mitterberger, M., Pallwein, L., et al. (2008). alpha-Blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms. BJU International, 101(3), 319–324. https://doi.org/10.1111/j.1464-410X.2007.07339.x.
Monaghan, T. F., Miller, C. D., Agudelo, C. W., et al. (2020). Cardiovascular risk independently predicts small functional bladder storage capacity. International Urology and Nephrology. https://doi.org/10.1007/s11255-020-02616-6.
Everaert, K., Herve, F., Bosch, R., et al. (2019). International Continence Society consensus on the diagnosis and treatment of nocturia. Neurourology and Urodynamics, 38(2), 478–498. https://doi.org/10.1002/nau.23939.
Funding
None.
Author information
Authors and Affiliations
Contributions
Conceptualization: JML, MDC, TFM; Methodology: JML, MDC, TFM; Formal Analysis and Investigation: JML, MDC, TFM; Writing—Original Draft Preparation: JML, TFM; Writing—Review and Editing: JML, MDC, JPW, KE, TDB, AJW, FCB, TFM; Funding Acquisition: N/A; Resources: N/A; Supervision: AJW, FCB.
Corresponding author
Ethics declarations
Conflict of interest
Jason M. Lazar has no direct or indirect commercial incentive associated with publishing this article and certifies that all conflicts of interest relevant to the subject matter discussed in the manuscript are the following: Dr. Weiss is a consultant for Ferring and the Institute for Bladder and Prostate Research, outside the submitted work. Dr. Everaert is a consultant and lecturer for Medtronic and Ferring and reports institutional grants from Allergan, Ferring, Astellas, and Medtronic, outside the submitted work. Dr. Wein has served as an advisor/consultant for Bulkamid, Medtronic, Serenity, Urovant, and Velicept, outside the submitted work. The additional authors have nothing to disclose.
Ethical Approval
The present analysis employed data from a publicly-available dataset and did not require approval from an ethical committee.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lazar, J.M., Chobufo, M.D., Weiss, J.P. et al. Nocturia is Associated with High Atherosclerotic Cardiovascular Disease Risk in Women: Results from the National Health and Nutrition Examination Survey. J Community Health 46, 854–860 (2021). https://doi.org/10.1007/s10900-021-00962-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10900-021-00962-9